Transmedics
TMDX
315 hedge funds and large institutions have $2.3B invested in Transmedics in 2024 Q4 according to their latest regulatory filings, with 74 funds opening new positions, 131 increasing their positions, 84 reducing their positions, and 125 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 84
0.02% more ownership
Funds ownership: 109.86% → 109.88% (+0.02%)
16% less funds holding
Funds holding: 373 → 315 (-58)
17% less call options, than puts
Call options by funds: $51.6M | Put options by funds: $62.5M
41% less first-time investments, than exits
New positions opened: 74 | Existing positions closed: 125
60% less capital invested
Capital invested by funds: $5.74B → $2.3B (-$3.44B)
90% less funds holding in top 10
Funds holding in top 10: 10 → 1 (-9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$175M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
+$85.8M |
| 3 |
LIP
Liontrust Investment Partners
London,
United Kingdom
|
+$52.6M |
| 4 |
UBS AM
Chicago,
Illinois
|
+$52M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$49.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$127M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$71.7M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$71.5M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$64.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$63.4M |
TMDX Hedge Fund Activity: Q4 2024 in Review
315 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q4 2024, worth a combined $2.3B — down 60% from $5.74B a quarter earlier.
Sellers outnumbered buyers: 125 funds closed out of TMDX and 74 opened new positions — a net loss of 51 holders — while 84 trimmed existing stakes and 131 added.
The largest buyer was Fidelity Investments, adding an estimated $175M. The largest seller was Lord, Abbett & Co, exiting entirely with an estimated $127M sold.
- 315 institutional investors held Transmedics (TMDX) as of Q4 2024, down from 373 in Q3 2024.
- Funds reported $2.3B of Transmedics stock for Q4 2024, down 60% quarter-over-quarter.
- 74 funds opened new Transmedics positions in Q4 2024 and 125 closed out, a net change of -51 holders.
- The largest Transmedics buyer in Q4 2024 was Fidelity Investments, an estimated $175M added.
- The largest Transmedics seller in Q4 2024 was Lord, Abbett & Co, an estimated $127M sold.
Based on aggregated 13F filings for Q4 2024.